Share
Endocrine Society to host virtual Science Writers Conference Nov. 14 Surging demand for a new generation of highly effective anti-obesity medications is creating interest in compounded versions of these medications. Endocrine Society experts will discuss the importance of prescribing FDA-approved medications to treat obesity during the Society’s Virtual Science Writers Conference on November 14. What:...
Share
Daniel Drucker, MD, recent winner of our Lifetime Achievement Laureate Award, the top honors in the field, shares his story as one of the pioneers in advancing next-generation anti-obesity medications such as Ozempic in a new video series on obesity care. Drucker, who is a senior investigator at the Lunenfeld-Tanenbaum Research Institute, Sinai Health, and a...
Share
A Town Hall sponsored by the Endocrine Society’s Early-Career Special Interest Group (SIG) provided attendees with insight into the professional journeys of a basic scientist, a translational scientist, and a physician-scientist. The Early-Career Special Interest Group (SIG) Webinar “Insider Insights in the Scientist Pathway” welcomed three highly accomplished professors last week, who each shared valuable...
Share
Endocrine Society members David J. Mangelsdorf, PhD; Erica Elizabeth Marsh, MD, MSCI; and Margaret M. McCarthy, PhD have been elected to the National Academy of Medicine (NAM). David J. Mangelsdorf, PhD, is professor and chair, department of pharmacology, and investigator, Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas. He was noted for...
Share
A new Scientific Statement released by the Endocrine Society highlights research gaps associated with the negative effects of opioid use on the endocrine system. The use and misuse of opioids are a growing global problem. Opioids are used to treat pain in people with cancer or other conditions (e.g., after an injury or surgery), however,...
Share
The Endocrine Society and Keystone Symposia, a nonprofit host of conferences and symposia on a range of life science and biomedical topics, will jointly host a series of three conferences to advance endocrine research. The three conferences will focus on diabetes, oncology, and cardiovascular disease — hormone-related conditions that have a major impact on public...
Share
A new virtual conference will explore how artificial intelligence (AI) can help healthcare providers and scientists efficiently analyze vast amounts of data and make more informed decisions, the Endocrine Society announced today. The Society will host its first-ever Artificial Intelligence in Healthcare Virtual Summit Nov. 8-9. The event will explore AI’s potential to revolutionize patient...
Share
Three Endocrine Society members have taken home the 2024 Lasker~DeBakey Clinical Medical Research Award. Joel F. Habener, MA, MD, chief of Laboratory of Molecular Endocrinology, Massachusetts General Hospital; Lotte Bjerre Knudsen, DMSc, chief scientific advisor and head of the GLP-1 Centre of Excellence at Novo Nordisk; and Svetlana Mojsov, PhD, research associate professor at Rockefeller...
